<DOC>
	<DOCNO>NCT00130182</DOCNO>
	<brief_summary>The purpose study investigate safety effectiveness two dose strength study drug compare placebo pediatric patient cystic fibrosis ( CF ) .</brief_summary>
	<brief_title>A Study Pediatric Patients With Cystic Fibrosis Lung Disease</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<criteria>Have confirm diagnosis CF Have FEV1 great equal 60 % Have oxygen saturation great equal 90 % room air Be clinically stable least 4 week prior screen Be able reproducibly perform spirometry maneuver Have clinically significant comorbidities Have change physiotherapy technique schedule within 7 day prior screen Using prior concurrent medication accord protocol</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>lung disease</keyword>
</DOC>